Therapeutics Acquisition Corp. License Agreements

2 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment dated November 8, 2022 to the Exclusive License and Commercialization Agreement dated December 16, 2020 between POINT; the Canadian Molecular Probe Consortium; the...
License Agreements
Therapeutics Acquisition Corp.
Biotechnology
2023
Exclusive License and Commercialization Agreement, dated December 16, 2020, by and between POINT Biopharma Inc., Canadian Molecular Probe Consortium, the Centre for Probe...
License Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021